Full Title
SuperHERO: A Phase II Trial Evaluating Radiotherapy Omission for Low-risk HER2-positive Breast CancerPurpose
To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.
Contact
For more information or to see if you can join this study, please call Dr. Lior Braunstein’s office at 201-775-7446.
Protocol
26-385
Investigator
Co-Investigators
Diseases
Locations
ClinicalTrials.gov ID
NCT07895511
ClinicalTrials.gov